LYKON, founded in 2015 and headquartered in Germany, is a forward-thinking digital health company operating in the Health Care and Internet industries. Under the mantra of Nutrition. Personalised., the company aims to revolutionize healthcare by empowering individuals to take control of their own health through personalized nutrition and medicine solutions.
LYKON's innovative approach involves offering DNA and blood tests that customers can conduct at home, enabling them to receive personalized health insights and nutrition recommendations. By focusing on user-friendly, at-home testing and providing clear, actionable results through a personalized online profile, LYKON is positioning itself in the growing market of personalized health services.
As of August 17, 2023, LYKON secured a €2.50M venture round investment led by Zintinus, underscoring investor confidence in its potential to reshape how people engage with their health.